Skip to main content

Table 1 Bio-nFeR pharmacokinetic parameters

From: A novel oral micellar fenretinide formulation with enhanced bioavailability and antitumour activity against multiple tumours from cancer stem cells

Bio-nFeR pharmacokinetic parameters

Bio-nFer Dose (mg/kg)

10

50

100

200

Cmax (ng/ml)

600.9

3654.7

5340.9

6837.8

Tmax (hr)

2

4

4

2

AUC 0-last (hr*ng/ml)

6745.4

39156.9

66323.6

112957.1

AUC inf (hr*ng/ml)

6812.1

39513.7

66751.7

114227.6

HL (hr)

7.48

7.32

6.49

7.16

  1. Pharmacokinetic parameters analysis in mice after single oral treatment of 4 doses of Bio-nFeR: 10, 50, 100 and 200 mg/ /kg. Cmax: maximum plasma concentration achieved after drug administration; Tmax: time until Cmax is reached; AUC last: experimental area under the concentration-time curve from time 0 to the last experimental point measured (Clast); AUC inf: AUC calculated from 0 to Clast added of the extrapolated portion of the AUC calculated by: AUCz = Clast/ke; HL: plasma half-life of the terminal phase calculated by: HL = 0.693/ke.